Abstract
During fasting, mammals maintain normal glucose homeostasis by stimulating hepatic gluconeogenesis1. Elevations in circulating glucagon and epinephrine, two hormones that activate hepatic gluconeogenesis, trigger the cAMP-mediated phosphorylation of cAMP response element–binding protein (Creb) and dephosphorylation of the Creb-regulated transcription coactivator-2 (Crtc2)—two key transcriptional regulators of this process2. Although the underlying mechanism is unclear, hepatic gluconeogenesis is also regulated by the circadian clock, which coordinates glucose metabolism with changes in the external environment3,4,5,6. Circadian control of gene expression is achieved by two transcriptional activators, Clock and Bmal1, which stimulate cryptochrome (Cry1 and Cry2) and Period (Per1, Per2 and Per3) repressors that feed back on Clock-Bmal1 activity. Here we show that Creb activity during fasting is modulated by Cry1 and Cry2, which are rhythmically expressed in the liver. Cry1 expression was elevated during the night-day transition, when it reduced fasting gluconeogenic gene expression by blocking glucagon-mediated increases in intracellular cAMP concentrations and in the protein kinase A–mediated phosphorylation of Creb. In biochemical reconstitution studies, we found that Cry1 inhibited accumulation of cAMP in response to G protein–coupled receptor (GPCR) activation but not to forskolin, a direct activator of adenyl cyclase. Cry proteins seemed to modulate GPCR activity directly through interaction with Gsα. As hepatic overexpression of Cry1 lowered blood glucose concentrations and improved insulin sensitivity in insulin-resistant db/db mice, our results suggest that compounds that enhance cryptochrome activity may provide therapeutic benefit to individuals with type 2 diabetes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nordlie, R.C., Foster, J.D. & Lange, A.J. Regulation of glucose production by the liver. Annu. Rev. Nutr. 19, 379–406 (1999).
Screaton, R.A. et al. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 119, 61–74 (2004).
Green, C.B., Takahashi, J.S. & Bass, J. The meter of metabolism. Cell 134, 728–742 (2008).
Kida, K. et al. The circadian change of gluconeogenesis in the liver. J. Biochem. 88, 1009–1013 (1980).
Gelling, R.W. et al. Lower blood glucose, hyperglucagonemia and pancreatic α cell hyperplasia in glucagon receptor knockout mice. Proc. Natl. Acad. Sci. USA 100, 1438–1443 (2003).
Ramsey, K.M., Marcheva, B., Kohsaka, A. & Bass, J. The clockwork of metabolism. Annu. Rev. Nutr. 27, 219–240 (2007).
Dentin, R. et al. Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 449, 366–369 (2007).
Vollmers, C. et al. Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression. Proc. Natl. Acad. Sci. USA 106, 21453–21458 (2009).
Panda, S. et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109, 307–320 (2002).
Ueda, H.R. A transcription factor response element for gene expression during circadian night. Nature 418, 534–539 (2002).
Zhang, X. et al. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation and target gene activation in human tissues. Proc. Natl. Acad. Sci. USA 102, 4459–4464 (2005).
Aton, S.J., Colwell, C.S., Harmar, A.J., Waschek, J. & Herzog, E.D. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat. Neurosci. 8, 476–483 (2005).
Pulivarthy, S.R. et al. Reciprocity between phase shifts and amplitude changes in the mammalian circadian clock. Proc. Natl. Acad. Sci. USA 104, 20356–20361 (2007).
Li, C., Chen, P., Vaughan, J., Lee, K.-F. & Vale, W. Urocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasis. Proc. Natl. Acad. Sci. USA 104, 4206–4211 (2007).
van der Horst, G.T.J. et al. Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. Nature 398, 627–630 (1999).
O'Neill, J.S., Maywood, E.S., Chesham, J.E., Takahashi, J.S. & Hastings, M.H. cAMP-dependent signaling as a core component of the mammalian circadian pacemaker. Science 320, 949–953 (2008).
Dentin, R., Hedrick, S., Xie, J., Yates, J. III & Montminy, M. Hepatic glucose sensing via the CREB coactivator CRTC2. Science 319, 1402–1405 (2008).
Sato, T.K. et al. Feedback repression is required for mammalian circadian clock function. Nat. Genet. 38, 312–319 (2006).
Sanada, K., Harada, Y., Sakai, M., Todo, T. & Fukada, Y. Serine phosphorylation of mCRY1 and mCRY2 by mitogen-activated protein kinase. Genes Cells 9, 697–708 (2004).
Acknowledgements
We thank L. Vera, A. Luzader, E. Rodrigo and X. Li for adenoviral injections, J. Altarejos and M. Lindstrom for mouse blood collection and glucose measurement and N. Goebel for preparing primary hepatocytes. We also thank M. Yamout and P. E. Wright for stimulating discussions and N. Gekakis, D. Welsh and S. Wang for reading the manuscript. This is manuscript 080809 of Genomics Institute of the Novartis Research Foundation, and the research was supported in part by grants from the US National Institutes of Health (R01 GM074868 and R01 MH051573 to S.A.K; R01 DK083834 and R01 DK049777 to M.M.). Y.L. is supported by the “One Hundred Talents” Program of the Chinese Academy of Sciences (No. 2010OHTP08) and Shanghai Pujiang Program (10PJ1411200) in China, and D.A.N. is supported by a fellowship (GM083585) from the US National Institutes of Health.
Author information
Authors and Affiliations
Contributions
E.E.Z. and S.A.K. conceived the project. E.E.Z., Y.L., M.M. and S.A.K. designed the research. E.E.Z., Y.L., R.D., P.Y.P., A.C.L., T.H., D.A.N., X.S., S.L. and Y.K. performed the experiments. E.E.Z. and Y.L. analyzed the data. E.E.Z., Y.L., D.A.B., M.M. and S.A.K. wrote the paper. This work is also supported in part by the Clayton Medical Research Foundation (CMRF), and M.M. is a Senior CMRF Investigator. M.M. is also supported by the Kieckhefer Foundation.
Corresponding authors
Ethics declarations
Competing interests
S.A.K. is a cofounder of ReSet Therapeutics and is a member of its Scientific Advisory Board.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–8 and Methods (PDF 562 kb)
Rights and permissions
About this article
Cite this article
Zhang, E., Liu, Y., Dentin, R. et al. Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis. Nat Med 16, 1152–1156 (2010). https://doi.org/10.1038/nm.2214
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2214
This article is cited by
-
Circadian regulation of liver function: from molecular mechanisms to disease pathophysiology
Nature Reviews Gastroenterology & Hepatology (2023)
-
Effect of early vs. late time-restricted high-fat feeding on circadian metabolism and weight loss in obese mice
Cellular and Molecular Life Sciences (2023)
-
The relationship of genetic risk score with cardiometabolic risk factors: a cross-sectional study
BMC Cardiovascular Disorders (2022)
-
Circadian Regulation and Clock-Controlled Mechanisms of Glycerophospholipid Metabolism from Neuronal Cells and Tissues to Fibroblasts
Molecular Neurobiology (2022)
-
Circadian rhythms affect bone reconstruction by regulating bone energy metabolism
Journal of Translational Medicine (2021)